Medicalia.org

by Internet Medical Society

Ibrutinib: mantle cell lymphoma treatment

The medicine Ibrutinib is sold under the trade name Imbruvica, which is used in treating patients with mantle cell lymphoma (MCL) who have received at least one prior therapy, chronic lymphocytic leukemia (CLL) who have received at least one prior therapy, chronic lymphocytic leukemia (CLL) with 17p deletion and Waldenström’s macroglobulinemia. Capsules of Ibrutinib are supplied in 140 mg to administer orally via the mouth. One should administer Ibrutinib as per the prescription provided by healthcare professionals. The active ingredient in the capsule is Ibrutinib, with inactive ingredients such as croscarmellose sodium, magnesium stearate, microcrystalline cellulose, and sodium lauryl sulfate.

Ibrutinib 140 mg is easily available from several certified medicine suppliers at a reasonable price. To know more about the drug Ibrutinib, dial the toll-free no. 18008891064.

Views: 2

Reply to This

Advertisement

Interested in advertising on Medicalia.org?

-------------------------

-------------------------

-------------------------

INTERNATIONAL ARCHIVES OF MEDICINE

Submit your manuscript

© 2022   Created by Network Admin.   Powered by

Badges  |  Report an Issue  |  Terms of Service